ConductScience.org, home

Paper36979695

Computational and Preclinical Analysis of 2-(4-Methyl)benzylidene-4,7-dimethyl Indan-1-one (IPX-18): A Novel Arylidene Indanone Small Molecule with Anti-Inflammatory Activity via NF-κB and Nrf2 Signaling.

Gahtani RM and 2 others. Biomedicines, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Computational and Preclinical Analysis of 2-(4-Methyl)benzylidene-4,7-dimethyl Indan-1-one (IPX-18): A Novel Arylidene Indanone Small Molecule with Anti-Inflammatory Activity via NF-κB and Nrf2 Signaling. Papers, record 36979695. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979695

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computational and Preclinical Analysis of 2-(4-Methyl)benzylidene-4,7-dimethyl Indan-1-one (IPX-18): A Novel Arylidene Indanone Small Molecule with Anti-Inflammatory Activity via NF-κB and Nrf2 Signaling.
PubMed
Journal
Biomedicines
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.28
iCite
Revised in PubMed
2023-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gahtani RMReem M
2Shaikh AAhmadhttps://orcid.org/0000-0002-7001-4200
3Kamli HHossamhttps://orcid.org/0000-0003-1333-9188

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R.G.P.1/191/43King Khalid UniversityPubMed

Source PubMed

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122920722Self-amplification mechanisms of mast cell activation: a new look in allergy.Curr Mol Med2012https://conductscience.org/library/papers/22920722PubMed
234353411A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.Oncol Res2022https://conductscience.org/library/papers/34353411PubMed
314678266Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.Clin Exp Immunol2004https://conductscience.org/library/papers/14678266PubMed
425666548Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice.Sci Rep2015https://conductscience.org/library/papers/25666548PubMed
524024177Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.Redox Biol2013https://conductscience.org/library/papers/24024177PubMed
629115410Peanut arachidin-1 enhances Nrf2-mediated protective mechanisms against TNF-α-induced ICAM-1 expression and NF-κB activation in endothelial cells.Int J Mol Med2018https://conductscience.org/library/papers/29115410PubMed
729719375Design, synthesis, and structure-activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injury.Drug Des Devel Ther2018https://conductscience.org/library/papers/29719375PubMed
823435331Neutrophil recruitment and function in health and inflammation.Nat Rev Immunol2013https://conductscience.org/library/papers/23435331PubMed
926850997N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.Glycobiology2016https://conductscience.org/library/papers/26850997PubMed
1016899107Interleukin-6 and chronic inflammation.Arthritis Res Ther2006https://conductscience.org/library/papers/16899107PubMed
1117889545Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures.Bioorg Med Chem2007https://conductscience.org/library/papers/17889545PubMed
1234727304
High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.
J Comput Aided Mol Des2021https://conductscience.org/library/papers/34727304PubMed
1331353586Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.J Food Biochem2019https://conductscience.org/library/papers/31353586PubMed
1420608915Robust expression of CCR3 as a single basophil selection marker in flow cytometry.Allergy2011https://conductscience.org/library/papers/20608915PubMed
1517334670Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.Inflamm Res2007https://conductscience.org/library/papers/17334670PubMed
1612417884Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration.J Allergy Clin Immunol2002https://conductscience.org/library/papers/12417884PubMed
1715522594In situ measurement of degranulation as a biosensor based on RBL-2H3 mast cells.Biosens Bioelectron2004https://conductscience.org/library/papers/15522594PubMed
1834712428The SMAC mimetic AT-101 exhibits anti-tumor and anti-metastasis activity in lung adenocarcinoma cells by the IAPs/ caspase-dependent apoptosis and p65-NFƙB cross-talk.Iran J Basic Med Sci2021https://conductscience.org/library/papers/34712428PubMed
1918241676NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK.Biochim Biophys Acta2008https://conductscience.org/library/papers/18241676PubMed
2021195808Inflammation as "common soil" of the multifactorial diseases.Autoimmun Rev2011https://conductscience.org/library/papers/21195808PubMed

See all 47 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42593645Potential of imidazole derivatives in reducing vascular complications in experimental diabetes.Mol Cell Biochem2026https://conductscience.org/library/papers/42593645PubMed
40109858Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2V617F mutation in myeloproliferative neoplasms.Oncol Res2025https://conductscience.org/library/papers/40109858PubMed
39367036Design, synthesis, and biological evaluation of novel imidazole derivatives as analgesic and anti-inflammatory agents: experimental and molecular docking insights.Sci Rep2024https://conductscience.org/library/papers/39367036PubMed
38543070Approaches, Strategies and Procedures for Identifying Anti-Inflammatory Drug Lead Molecules from Natural Products.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38543070PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36979695

GET https://conductscience.org/api/papers/v1/36979695/references?page=2